Von Hippel-Lindau disease: Protocol for diagnostic and periodical clinical monitoring;De ziekte van Von Hippel-Lindau: Protocol voor diagnostiek en periodiek klinisch onderzoek

Nederlands Tijdschrift voor Geneeskunde

Volumn 144, Issue 11, 2000, Pages 505-509

  Hes, F J ^a   Van Der Luijt, R B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT DISORDER; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; NETHERLANDS; VON HIPPEL LINDAU DISEASE;

CLINICAL PROTOCOLS; DISEASE MANAGEMENT; GENETIC SCREENING; HIPPEL-LINDAU DISEASE; HUMANS; NEOPLASMS; NETHERLANDS;

EID: 0034635882     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Maher ER, Kaelin Jr WG. Von Hippel-Lindau disease. Medicine (Baltimore) 1997;76:381-91.
2. Neumann HP, Lips CJM, Hsia YE, Zbar B. Von Hippel-Lindau syndrome. Brain Pathol 1995;5:181-93.
3. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, et al. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991; 28:443-7.
4. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990;77:1151-63.
5. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995;194:629-42.
6. Seizinger BR, Smith DI, Filling-Katz MR, Neumann H, Green JS, Choyke PL, et al. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease. Proc Natl Acad Sci USA 1991;88:2864-8.
7. Melmon KL, Rosen SW. Lindau's disease. Review of the literature and study of a large kindred. Am J Med 1964;36:595-617.
8. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
9. Knudson jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-3.
10. Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, et al. Improved detection of germlinc mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998;12:417-23.
11. Olschwang S, Richard S, Boisson C, Giraud S, Laurent-Puig P, Resche F, et al. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Hum Mutat 1998;12:424-30.
12. Neumann HP, Bender BU, Berger DP, Laubenberger J, Schultze-Seemann W, Wetterauer U, et al. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 1998;160:1248-54.
13. Brauch H, Hoeppner W, Jahnig H, Wohl T, Engelhardt D, Spelsberg F, et al. Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene. J Clin Endocrinol Metab 1997;82:4101-4.
14. Harst E van der, Krijger RR de, Dinjens WN, Weeks LE, Bonjer HJ, Bruining HA, et al. Germline mutations in the vhl gene in patients presenting with phaeochromocytomas. Int J Cancer 1998;77:337-40.
15. Slebbins CE, Kaelin jr WG, Pavletich NP. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 1999;284:455-61.
16. Webster AR, Richards FM, MacRonald FE, Moore AT, Maher ER. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am J Hum Genet 1998;63:1025-35.
17. Manski TJ, Heffner DK, Glenn GM, Patronas NJ, Pikus AT, Katz D, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA 1997;277:1461-6.
18. Richard S, Campello C, Taillandier L, Parker F, Resche F. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group. J Intern Med 1998;243: 547-53.
19. Binkovitz LA, Johnson CD, Stephens DH. Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias. Am J Roentgenol 1990;155:501-5.
20. Choyke PL, Glenn GM, Wagner JP, Lubensky IA, Thakore K, Zbar B, et al. Epididymal eystadenomas in von Hippel-Lindau disease. Urology 1997;49:926-31.
21. Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 1999;117:371-8.
22. Neumann HP. Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome. Vasa 1987;16:220-6.
23. Veltman GAM, Arntzenius AB, Oosterwijk JC, Lyeklama à Nijeholt AAB, Roelfsema F. Tumoren buiten het centrale zenuwstelsel bij de ziekte van Von Hippel-Lindau. Ned Tijdschr Geneeskd 1996;140:823-6.
24. Los M, Links TP, Lenders JWM, Voest EE. De ziekte van Von Hippel-Lindau. Ned Tijdschr Geneeskd 2000;144:497-501.